In part two of an exclusive interview with Creso Pharma, chief executive Will Lay and executive director Bruce Linton map out the future prospects for the ASX-listed enterprise.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Will Lay is no stranger to the occasional business deal.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...